Use of biomarkers for assessing radiation injury and efficacy of countermeasures

Several candidate drugs for acute radiation syndrome (ARS) have been identified that have low toxicity and significant radioprotective and radiomitigative efficacy. Inasmuch as exposing healthy human volunteers to injurious levels of radiation is unethical, development and approval of new radiation...

Descripción completa

Detalles Bibliográficos
Autores principales: Singh, Vijay K, Newman, Victoria L, Romaine, Patricia LP, Hauer-Jensen, Martin, Pollard, Harvey B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2016
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4732464/
https://www.ncbi.nlm.nih.gov/pubmed/26568096
http://dx.doi.org/10.1586/14737159.2016.1121102

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4732464/
https://www.ncbi.nlm.nih.gov/pubmed/26568096
http://dx.doi.org/10.1586/14737159.2016.1121102

Ejemplares similares